Call us today or complete the form below
for a free evaluation of your case.
The imagery used on this website utilizes fictionalized events or scenes with participation of models.
When sodium-glucose cotransporter-2 (SGLT2) inhibitors were approved in 2013, many people with Type II diabetes breathed a sigh of relief. For most, this treatment helps to lower high blood sugar, but in rare cases, it can lead to a dangerous infection known as necrotizing fasciitis of the perineum. If you or a loved one have experienced this, call us today to ensure the clock doesn’t run out on your compensation claim.
Fournier’s gangrene is another name for necrotizing fasciitis of the perineum. The condition usually occurs in less than 2 out of every 100,000 American males annually. Women rarely experience the disease. Those who take SGLT2 inhibitors, however, saw a sharp uptick in the condition.
Necrotizing fasciitis of the perineum is a bacterial infection, and if left untreated, it can be a fatal condition. This is why it’s important to recognize the symptoms of Fournier’s gangrene and quickly seek medical attention.
An attorney with Fournier’s gangrene experience may be able to help recover compensation if you or a loved one experiences this condition. Unfortunately, there are filing deadlines. The most important thing is to seek medical assistance, but afterwards, call us immediately to ensure the statute of limitations doesn’t pass.
SGLT2 inhibitors help Type II diabetes patients by allowing their kidneys to remove more sugar. By doing this, the drugs lessened the chance of blindness, kidney damage, heart disease and nerve damage. There are several classes of these medications.
Empagliflozin (Syjardy, Glyxambi, Synjardy XR)
Ertugliflozin (Stelujan, Segluromet, Steglatro)
Dapagliflozin (Qtern, Xigduo, Farxiga)
Canagliflozin (Invokamet, Invokamet XR, Invokana)
These medications are produced by Merck, Janssen, Boehringer Ingelheim/Eli Lilly and AstraZeneca. Studies found that other Type II diabetes treatments, however, didn’t have the same potential for necrotizing fasciitis of the perineum.
Only 6 men using other diabetes medications were diagnosed with Fournier’s gangrene between 1984 and 2018. When looking at those using SGLT2 inhibitors, though, 7 men and 5 women were diagnosed in just the 5 years prior to 2018.
If you’re unlucky enough to develop this condition, call us immediately. Your medical bills can pile up quickly, and without legal help, you could be footing the bill yourself.
If you or a loved one have been diagnosed with Fournier’s gangrene, our legal professionals may be able to help. While SGLT2 inhibitors have done wonders in the field of diabetes treatment, they also left many people with a serious disease with a much worse prognosis than high blood sugar.
Contact us today if you have any questions about your Fournier’s gangrene diagnosis. We can let you know your legal options and get the ball rolling in order to fight for the compensation you deserve.
Duffy & Duffy secured a $4,725,000 settlement for a man who now has permanent physical and cognitive deficits as a result of an aortic root aneurysm. After his twin brother was diagnosed with the same condition, the client underwent a screening echocardiogram and a chest x-ray since he was at a higher risk. Tragically the aortic aneurysm was overlooked and ruptured 19 months later.
